尼比沃洛对勃起功能的影响:随机对照试验的系统综述和元分析
1Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, China.
The journal of sexual medicine
|December 23, 2024
概括
与甲醇相比,Nebivolol是一种第三代β抑制剂,显示出更好的勃起功能. 这一元分析提供了更强有力的证据,证明内比沃醇可以降低勃起功能障碍 (ED) 发生或进展的风险.
科学领域:
- 心血管药理学心血管药理学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 临床试验方法论 临床试验方法论
背景情况:
- 贝塔抑制剂在历史上与勃起功能障碍 (ED) 有关.
- 尼比沃洛 (Nebivolol) 是第三代β阻塞剂,具有血管扩张特性,可以减轻对勃起功能的负面影响.
- 之前关于内比沃洛对勃起功能影响的证据有限.
研究的目的:
- 进行随机对照试验 (RCT) 的系统审查和元分析.
- 为了确定与其他治疗方法相比,nebivolol对勃起功能的影响.
主要方法:
- 在PubMed,科克伦图书馆,科学网络和Embase中对RCT进行系统搜索,直到2023年10月.
- 使用Review Manager版本 5.3.0.0 进行的统计分析.
- 进行敏感性和子组分析以评估结果的稳定性.
主要成果:
- 包括4项涉及397人的RCT,比较了nebivolol和metoprolol.
- 尼比沃洛尔组显示国际勃起功能指数 (IIEF) -5得分显著更高 (MD 1.81,P < .0001).
- 敏感性和子组分析证实了结果的稳定性和一致性,异质性减少.
结论:
- 与甲醇相比,内比沃洛显著降低了ED发生或进展的风险.
- 无论基线勃起功能状态如何,都观察到这种效应.
- 这些发现提供了更强有力的证据,支持nebivolol对勃起功能的有利影响.
相关概念视频
Heart Failure Drugs: β-Blockers
315
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
315
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
129
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
129
Antihypertensive Drugs: Action of β1 Blockers
306
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
306
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
528
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
528
Antianginal Drugs: Nitrates and β-Blockers
517
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
517
Antihypertensive Drugs: Vasodilators
474
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
474


